Hangzhou Tigermed Consulting Co Ltd (3347)

Hong Kong
Currency in HKD
32.20
+3.60(+12.59%)
Closed
3347 Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
Unusual trading volume
Fair Value
Day's Range
28.7532.25
52 wk Range
24.5058.80
Key Statistics
Edit
Bid/Ask
32.20 / 32.25
Prev. Close
28.6
Open
29.1
Day's Range
28.75-32.25
52 wk Range
24.5-58.8
Volume
8.49M
Average Volume (3m)
1.67M
1-Year Change
36.15%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3347 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
39.24
Upside
+21.86%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Tigermed Company Profile

Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. In addition, the company offers patient recruitment, investment management, medical registration, pharmaceuticals and regulations consulting, drug safety, bioequivalence, and third-party training services, as well as chemistry, management, and controls services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.

Compare 3347 to Peers and Sector

Metrics to compare
3347
Peers
Sector
Relationship
P/E Ratio
46.5x24.6x−0.7x
PEG Ratio
−0.80−1.340.00
Price/Book
2.1x3.1x2.6x
Price / LTM Sales
6.6x4.2x3.1x
Upside (Analyst Target)
22.9%8.4%50.4%
Fair Value Upside
Unlock14.4%8.4%Unlock

Analyst Ratings

8 Buy
2 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 39.24
(+21.86% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.11
Dividend Yield
-
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 29, 2024
EPS / Forecast
0.4038 / 0.5899
Revenue / Forecast
1.87B / 2.22B
EPS Revisions
Last 90 days

FAQ

What Is the Tigermed (3347) Stock Price Today?

The Tigermed stock price today is 32.20.

What Stock Exchange Does Tigermed Trade On?

Tigermed is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Tigermed?

The stock symbol for Tigermed is "3347."

Does Tigermed Pay Dividends? What’s The Current Dividend Yield?

The Tigermed dividend yield is 1.94%.

What Is the Tigermed Market Cap?

As of today, Tigermed market cap is 47.81B.

What is Tigermed Earnings Per Share?

The Tigermed EPS is 1.11.

What Is the Next Tigermed Earnings Date?

Tigermed will release its next earnings report on 27 Mar 2025.

From a Technical Analysis Perspective, Is 3347 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.